3D Lung Epithelium via FGF WNT RA Signaling
Solution Overview
Problem
Current methods for differentiating human pluripotent stem cells into lung lineages lack predictive power due to gaps in understanding human lung development, particularly in maintaining distal tip progenitor cells and species-specific differences between mouse and human lung development.
Innovation Solution
The use of synergistic activation of FGF, WNT, and RA signaling pathways to promote the growth and maintenance of SOX9+/SOX2+ distal lung-bud progenitor cells in vitro, specifically in human pluripotent stem cell-derived ventral-anterior foregut spheroids, to induce 3-dimensional lung-like epithelium.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional differentiation methods are used to generate lung lineages from human pluripotent stem cells, then lung tissue can be obtained, but the predictive power is limited due to gaps in understanding human lung development
Solution Approach 1:
The patent applies parameter changes by systematically varying signaling pathway activation levels (WNT, FGF, RA) to optimize the differentiation process. By adjusting the parameters of signaling molecule concentrations and timing, the method achieves more reliable generation of distal tip progenitor cells with improved predictive power for human lung development
Solution Approach 2:
The patent employs feedback mechanisms by monitoring the expression of specific markers (SOX2, SOX9, NKX2-1) and adjusting differentiation conditions accordingly. This feedback loop allows refinement of the differentiation protocol to better predict and replicate human lung development processes
2Loss of information
If mouse models are used to study lung development, then mechanistic insights can be gained, but species-specific differences limit the applicability to human lung development
Solution Approach 1:
The patent segments the differentiation process into distinct stages that can be independently optimized. By dividing the complex differentiation into manageable phases (definitive endoderm formation, foregut specification, distal tip progenitor generation), the method can incorporate human-specific parameters at each stage, improving applicability to human lung development while retaining mechanistic insights
Solution Approach 2:
The patent applies local quality by implementing species-specific signaling conditions at different spatial and temporal points during differentiation. By tailoring the signaling environment to match human developmental requirements at specific stages, the method bridges the gap between mouse model insights and human applicability
3Productivity
If distal tip progenitor cells are maintained in culture, then expansion of progenitor population is achieved, but maintaining the undifferentiated state becomes challenging
Solution Approach 1:
The patent implements continuity of useful action by maintaining constant activation of WNT, FGF, and RA signaling pathways throughout the culture period. This continuous signaling prevents differentiation events that would otherwise occur during passaging and expansion, allowing sustained maintenance of the undifferentiated progenitor state while achieving population expansion
Solution Approach 2:
The patent applies preliminary action by pre-establishing the optimal signaling environment before expansion begins. By pre-configuring the culture conditions with appropriate signaling molecule concentrations and preparing the extracellular matrix environment, the method prevents differentiation during subsequent expansion passages
Data Source
AI summary
The invention disclosed herein generally relates to methods and systems for growing, expanding and/or obtaining 3-dimensional lung-like epithelium comprising cells having SOX9 protein activity and SOX2+ protein activity. In particular, the invention disclosed herein relates to methods and systems for growing human cells having SOX9 protein activity and SOX2+ protein activity in vitro, and for promoting pluripotent stem cell derived ventral-anterior foregut spheroid tissue into 3-dimensional lung-like epithelium comprising cells having SOX9 protein activity and SOX2+ protein activity.



